Ubs Asset Management Americas Inc Innoviva, Inc. Transaction History
Ubs Asset Management Americas Inc
- $477 Billion
- Q2 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Innoviva, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 212,504 shares of INVA stock, worth $3.7 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
212,504
Previous 171,116
24.19%
Holding current value
$3.7 Million
Previous $3.1 Million
37.62%
% of portfolio
0.0%
Previous 0.0%
Shares
27 transactions
Others Institutions Holding INVA
# of Institutions
283Shares Held
80.4MCall Options Held
10.3KPut Options Held
161K-
Black Rock Inc. New York, NY9.63MShares$168 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.18MShares$125 Million0.0% of portfolio
-
Putnam Investments LLC Boston, MA6.27MShares$109 Million0.14% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny4.76MShares$82.9 Million0.14% of portfolio
-
Dimensional Fund Advisors LP Austin, TX4.29MShares$74.8 Million0.02% of portfolio
About Innoviva, Inc.
- Ticker INVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 69,706,000
- Market Cap $1.21B
- Description
- Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a ...